Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Beta Drugs IPO and Kaarya Facilities IPO.
Beta Drugs IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Kaarya Facilities IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | First Overseas Capital Limited |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | ||
| RHP | RHP  |
|
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹19.52 Cr whereas the issue size of the Kaarya Facilities IPO is up to ₹6.40 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Kaarya Facilities IPO is ₹40.00 per share.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹40.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 22,96,000 shares | 15,99,000 shares |
| Issue Size Total (Amount) | up to ₹19.52 Cr | up to ₹6.40 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Kaarya Facilities IPO opens on Oct 12, 2017. The closing date of Beta Drugs IPO and Kaarya Facilities IPO is Oct 04, 2017, and Oct 17, 2017, respectively.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Oct 12, 2017 |
| Issue Close | Oct 04, 2017 | Oct 17, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to Kaarya Facilities IPO P/E ratio of .
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Beta Drugs IPO retail investors (RII) are offered while in Kaarya Facilities IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Beta Drugs IPO and in Kaarya Facilities IPO.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Beta Drugs IPO subscribed in total, whereas Kaarya Facilities IPO subscribed .
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
